The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 352:2642-2644 June 23, 2005 Number 25
NextNext

Type 1 Diabetes — Does Suppressing T Cells Increase Insulin?
Åke Lernmark, Med.Dr.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Keymeulen, B.
-PubMed Citation
During the ominous prelude to the onset of type 1 diabetes, the pancreatic-islet beta cells become the targets of a specific autoimmune attack, which ultimately results in diabetes. Although major advances have led to an improved understanding of this disease, important gaps in knowledge must be bridged before insulin replacement is shelved forever. The report by Keymeulen et al.1 in this issue of the Journal is further testimony to how complicated it will be to find a treatment that is superior to insulin alone.

The development of type 1 diabetes may be viewed as a two-step process. In the first . . . [Full Text of this Article]


Source Information

From the Department of Medicine, University of Washington, Seattle.



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.